577 related articles for article (PubMed ID: 19761558)
1. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
2. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
4. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
5. Paramyxovirus infection in lung transplant recipients.
Wendt CH; Fox JM; Hertz MI
J Heart Lung Transplant; 1995; 14(3):479-85. PubMed ID: 7654733
[TBL] [Abstract][Full Text] [Related]
6. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
[TBL] [Abstract][Full Text] [Related]
7. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
Hynicka LM; Ensor CR
Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
McCurdy LH; Milstone A; Dummer S
J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
[TBL] [Abstract][Full Text] [Related]
11. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.
Hopkins P; McNeil K; Kermeen F; Musk M; McQueen E; Mackay I; Sloots T; Nissen M
Am J Respir Crit Care Med; 2008 Oct; 178(8):876-81. PubMed ID: 18658110
[TBL] [Abstract][Full Text] [Related]
12. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections.
Fuehner T; Dierich M; Duesberg C; DeWall C; Welte T; Haverich A; Warnecke G; Simon AR; Gottlieb J
Antivir Ther; 2011; 16(5):733-40. PubMed ID: 21817195
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
Hashmi NA; Cosgrove JF; MacMahon P
Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
